Yongchang Zheng - Search Results

Year	Number of Results
2014	2
2015	2
2016	4
2017	10
2018	8
2019	8
2020	9
2021	13
2022	15
2023	13
2024	1

1

Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure.

Yang H, Sun L, Pang Y, Hu D, Xu H, Mao S, Peng W, Wang Y, Xu Y, Zheng YC, Du S, Zhao H, Chi T, Lu X, Sang X, Zhong S, Wang X, Zhang H, Huang P, Sun W, Mao Y. Yang H, et al. Gut. 2021 Mar;70(3):567-574. doi: 10.1136/gutjnl-2019-319960. Epub 2020 May 20. Gut. 2021. PMID: 32434830 Free PMC article.

2

Soft-tissue-segmentation methods during image-guided precision liver surgery.

Zheng Y, He L, Yang H, Bai Y, Xie F, Kang K, Wang X. Zheng Y, et al. Gastroenterol Rep (Oxf). 2018 Aug;6(3):239-241. doi: 10.1093/gastro/goy028. Epub 2018 Jul 31. Gastroenterol Rep (Oxf). 2018. PMID: 30151209 Free PMC article. No abstract available.

3

Extracellular Vesicles in Tumor Diagnosis: A Mini-Review.

Yu S, Huang M, Wang J, Zheng Y, Xu H. Yu S, et al. Among authors: zheng y. Curr Mol Med. 2021;21(7):596-606. doi: 10.2174/1573405616666201209103154. Curr Mol Med. 2021. PMID: 33297914 Review.

4

Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications.

Dong Y, He Q, Chen X, Yang F, He L, Zheng Y. Dong Y, et al. Among authors: zheng y. Front Oncol. 2023 Jun 28;13:1194405. doi: 10.3389/fonc.2023.1194405. eCollection 2023. Front Oncol. 2023. PMID: 37448518 Free PMC article. Review.

5

MCMs in Cancer: Prognostic Potential and Mechanisms.

Yu S, Wang G, Shi Y, Xu H, Zheng Y, Chen Y. Yu S, et al. Among authors: zheng y. Anal Cell Pathol (Amst). 2020 Feb 3;2020:3750294. doi: 10.1155/2020/3750294. eCollection 2020. Anal Cell Pathol (Amst). 2020. PMID: 32089988 Free PMC article. Review.

6

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Wang AQ, Zheng YC, Du J, Zhu CP, Huang HC, Wang SS, Wu LC, Wan XS, Zhang HH, Miao RY, Sang XT, Zhao HT. Wang AQ, et al. World J Gastroenterol. 2016 May 14;22(18):4459-65. doi: 10.3748/wjg.v22.i18.4459. World J Gastroenterol. 2016. PMID: 27182157 Free PMC article. Review.

7

Fluorescence-guided surgery in cancer treatment: current status and future perspectives.

Zheng Y, Yang H, Wang H, Kang K, Zhang W, Ma G, Du S. Zheng Y, et al. Ann Transl Med. 2019 Mar;7(Suppl 1):S6. doi: 10.21037/atm.2019.01.26. Ann Transl Med. 2019. PMID: 31032287 Free PMC article. No abstract available.

8

Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing.

Yang F, Deng K, Zheng H, Liu Z, Zheng Y. Yang F, et al. Among authors: zheng y. Ann Hepatol. 2022 Mar-Apr;27(2):100677. doi: 10.1016/j.aohep.2022.100677. Epub 2022 Jan 28. Ann Hepatol. 2022. PMID: 35093601 Free article. Review.

9

Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians.

Deng K, Xing J, Xu G, Jin B, Wan X, Zheng Y, Du S, Sang X. Deng K, et al. Among authors: zheng y. Cancer Cell Int. 2023 Oct 13;23(1):239. doi: 10.1186/s12935-023-03092-5. Cancer Cell Int. 2023. PMID: 37833757 Free PMC article. Review.

10

Exosomal circ-PTPN22 and circ-ADAMTS6 mark T cell exhaustion and neutrophil extracellular traps in Asian intrahepatic cholangiocarcinoma.

Wang X, Wang G, Wu Z, Dong Y, Shi Y, Yang F, Chen X, Wang J, Du S, Xu H, Zheng Y. Wang X, et al. Among authors: zheng y. Mol Ther Nucleic Acids. 2022 Dec 23;31:151-163. doi: 10.1016/j.omtn.2022.12.012. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2022. PMID: 36700045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year